4:07 PM ET
10-Q
Financial Results
Medicus Pharma Q3 2026 Results: Net Loss of $15.2M, Loss Narrows
Medicus Pharma Ltd. reported a net loss of $35.9 million for the nine months ended September 30, 2026, driven by $10 million in IPR&D charges and increased R&D spending. The company significantly strengthened its cash position through $17.2 million in ATM proceeds and $22 million from debentures, though it maintains a total shareholders' deficit of $10.5 million.
- Key figure
- Net loss $15.2M